Alok Sonig - Mar 6, 2024 Form 4 Insider Report for BAXTER INTERNATIONAL INC (BAX)

Role: EVP,Group President, Pharma
Signature: /s/ Ellen K. Bradford, as attorney in-fact for Alok Sonig
Stock symbol: BAX
Transactions as of: Mar 6, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/8/2024, 04:11 PM
Previous filing: Mar 5, 2024
Next filing: Sep 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BAX	Common Stock, $1 par value	Award	$0	+83.4K	+276.91%	$0.00	113K	Mar 6, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	For 2024, the annual equity grant for the reporting person consisted solely of restricted stock units (RSUs). The reporting person received a grant of RSUs which are scheduled to vest in three equal annual installments beginning on March 6, 2025, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

Content

For 2024, the annual equity grant for the reporting person consisted solely of restricted stock units (RSUs). The reporting person received a grant of RSUs which are scheduled to vest in three equal annual installments beginning on March 6, 2025, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.